Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Podiatry | Immunology | Infections and Infectious Diseases

Warts Clinical Trials

A listing of Warts medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


California

City of Hope Medical Center
Duarte California 91010

Patients are needed to participate in a clinical research study of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis, survey administration and medical chart review to evaluate Cancer Survivor or Human Papilloma Virus Infection

Call for Information (Investigational Site 0008)
Redlands California 92373

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Call for Information (Investigational Site 0213)
Spring Valley California 91978

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Call for Information (Investigational Site 0009)
Valley Village California 91607

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Call for Information (Investigational Site 0215)
Walnut Creek California 94598

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Connecticut

Yale School of Medicine
New Haven Connecticut 06519

A clinical trial to evaluate treatments using Occlusive Heat Patch for patients with Verruca (Warts)

District of Columbia

Childrens National Medical Center
Washington District of Columbia 20010

A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts

Georgetown University Hospital
Washington District of Columbia 20007

A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts

Georgia

Emory University School Of Medicine
Atlanta Georgia 30308

Patients are needed to participate in a clinical research study of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis, survey administration and medical chart review to evaluate Cancer Survivor or Human Papilloma Virus Infection

Kentucky

Call for Information (Investigational Site 0212)
Bardstown Kentucky 40004

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Massachusetts

Call for Information (Investigational Site 0002)
Woburn Massachusetts 01801

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Michigan

University of Michigan
Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis, survey administration and medical chart review to evaluate Cancer Survivor or Human Papilloma Virus Infection

Nebraska

Call for Information (Investigational Site 0004)
Omaha Nebraska 68131

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Ohio

Call for Information (Investigational Site 0214)
Cleveland Ohio 44121

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Tennessee

Saint Jude Childrens Research Hospital
Memphis Tennessee 38105

Patients are needed to participate in a clinical research study of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis, survey administration and medical chart review to evaluate Cancer Survivor or Human Papilloma Virus Infection

Texas

Call for Information (Investigational Site 0007)
Galveston Texas 77555

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Utah

Call for Information (Investigational Site 0010)
South Jordan Utah 84095

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Virginia

Call for Information (Investigational Site 0001)
Newport News Virginia 23606

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Sentara Norfolk General Hospital
Norfolk Virginia 23507

A clinical trial to evaluate treatments using Gardasil for patients with Genital Human Papilloma Virus Infection

Canada

Merck Canada
Kirkland Quebec H9H 3L1

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Chile

Merck Sharp & Dohme (I.A.) Corp.
Santiago

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Colombia

MDS Colombia SAS
Bogota

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Czech Republic

Merck Sharp and Dohme s.r.o.
Praha

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Denmark

Dermatology Clinic, Vesterbro
Aalborg DK-9000

A Phase 2 clinical study for patients with Cutaneous Warts

Marselisborg University Hospital
Aarhus C DK-8000

A Phase 2 clinical study for patients with Cutaneous Warts

Bispebjerg University Hospital
Copenhagen NV DK-2400

A Phase 2 clinical study for patients with Cutaneous Warts

Merck Sharp & Dohme
Glostrup

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Gentoftte Amtssygehus
Hellerup DK-2900

A Phase 2 clinical study for patients with Cutaneous Warts

View More »

Odense University Hospital
Odense DK-5000

A Phase 2 clinical study for patients with Cutaneous Warts

France

Hopital Henri Mondor-Dept of Dermatology
Creteil 94010

Patients are needed to participate in a clinical research study evaluating AP611074 and Placebo for the treatment of Anogenital Warts, Condylomata Acuminata or Human Papillomavirus Infection

SGS Aster
Paris 75014

Patients are needed to participate in a clinical research study evaluating AP611074 and Placebo for the treatment of Anogenital Warts, Condylomata Acuminata or Human Papillomavirus Infection

Israel

Merck Sharp & Dohme Co. Ltd.
Hod Hasharon

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Japan

MSD K.K.
Chiyoda-Ku, Tokyo 102-8667

A clinical trial seeking patients for a research study for the treatment of Anogenital Human Papilloma Virus Infection or Condyloma Acuminata

Korea, Republic of

MSD Korea LTD
Seoul

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Malaysia

MSD
Petaling Jaya

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Norway

MSD Norge A/S
Drammen

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Spain

Merck Sharp and Dohme de Espana S.A.
Madrid

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Taiwan

National Cheng Kung University Hospital
Tainan 744

A clinical research study of SR-T100 gel with 2.3% of SM in Solanum undatum plant extract for the treatment of Vulvar Intraepithelial Neoplasia or Genital Warts

Thailand

MSD (Thailand) Ltd.
Bangkok

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Turkey

Merck Sharp & Dohme Ilaclari Ltd. Sti
Istanbul

A Phase 3 clinical study for patients with Human Papillomavirus Infection